Requirement for epidermal growth factor receptor tyrosine kinase and for 12-lipoxygenase activity in the expression of 12-lipoxygenase in human epidermoid carcinoma cells

Biochemical Pharmacology

Volumn 53, Issue 7, 1997, Pages 937-942

  Hagmann, Wolfgang ^a   Borgers, Susanne ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

12 lipoxygenase; 12 lipoxygenase inhibitor; EGF R tyrosine kinase inhibitor; epidermal growth factor; tyrosine kinase

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4,5 DIANILINOPHTHALIMIDE DERIVATIVE; ANTINEOPLASTIC AGENT; ARACHIDONATE 12 LIPOXYGENASE; EPIDERMAL GROWTH FACTOR RECEPTOR; PHTHALIMIDE DERIVATIVE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL COMMUNICATION; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ARACHIDONATE 12-LIPOXYGENASE; BIOTIN; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; PHALLOIDINE; PHTHALIMIDES; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030919033     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00833-7     Document Type: Article

References (37)

1. Carpenter G and Cohen S, Epidermal growth factor. J Biol Chem 265: 7709-7712, 1990.
2. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL and Lee DC, Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61: 1121-1135, 1990.
3. Velu TJ, Beguinot L, Vass WC, Willingham MC, Merlino GT, Pastan I and Lowy DR, Epidermal growth factor-dependent transformation by a human EGF receptor protooncogene. Science 238: 1408-1410, 1987.
4. 2 activity by epidermal growth factor in CHO cells transfected with human EGF receptor. Biochem J 274: 715-721, 1991.
5. Nishibe S, Wahl MI, Hernandez-Sotomayor SMT, Tonks NK, Rhee SG and Carpenter G, Increase of the catalytic activity of phospholipase C-γ1 by tyrosine phosphorylation. Science 250: 1253-1256, 1990.
6. Fisher GJ, Henderson PA, Vorhees JJ and Baldassare JJ, Epidermal growth factor-induced hydrolysis of phosphatidylcholine by phospholipase D and phospholipase C in human dermal fibroblasts. J Cell Physiol 146: 309-317, 1991.
7. 4 production. Cell 69: 295-303, 1992.
8. Glasgow WC, Afshari CA, Barrett JC and Eling TE, Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts. J Biol Chem 267: 10771-10779, 1992.
9. Liu Y-W, Asaoka Y, Suzuki H, Yoshimoto T, Yamamoto S and Chang W-C, Induction of 12-lipoxygenase expression by epidermal growth factor is mediated by protein kinase C in A431 cells. J Pharmacol Exp Ther 271: 567-573, 1994.
10. Chang W-C, Ning C-C, Lin MT and Huang J-D, Epidermal growth factor enhances a microsomal 12-lipoxygenase activity in A431 cells. J Biol Chem 267: 3657-3666, 1992.
11. Chang WC, Liu YW, Ning CC, Suzuki H, Yoshimoto T and Yamamoto S, Induction of arachidonate 12-lipoxygenase mRNA by epidermal growth factor in A431 cells. J Biol Chem 268: 18734-18739, 1993.
12. Hagmann W, Gao X, Timar J, Chen YQ, Strohmaier A-R, Fahrenkopf C, Kagawa D, Lee M, Zacharek A and Honn KV, 12-Lipoxygenase in A431 cells: Genetic identity, modulation of expression, and intracellular localization. Exp Cell Res 228: 197-205, 1996.
13. Honn KV, Tang DG, Gao X, Butovich IA, Liu B, Timar J and Hagmann W, 12-Lipoxygenases and 12(S)-HETE: Role in cancer metastasis. Cancer Metastasis Rev 13: 365-396, 1994.
14. Grossi IM, Fitzgerald LA, Umbarger LA, Nelson KK, Diglio CA, Taylor JD and Honn KV, Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/ IIIa receptor and tumor cell adhesion by lipoxygenase products. Cancer Res 49: 1029-1037, 1989.
15. Chopra H, Timar J, Chen YQ, Rong X, Grossi IM, Fitzgerald LA, Taylor JD and Honn KV, The lipoxygenase metabolite 12(S)-HETE induces cytoskeleton-dependent increase in surface expression of integrin αIIbβ3 on melanoma cells. Int J Cancer 49: 774-786, 1991.
16. Honn KV, Grossi IM, Diglio CA, Wojtukiewicz M and Taylor JD, Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)-HETE-induced endothelial cell retraction. FASEB J 3: 2285-2293, 1989.
17. Timar J, Silletti S, Bazaz R, Raz A and Honn KV, Regulation of melanoma cell motility by the lipoxygenase metabolite 12(S)-HETE. Int J Cancer 55: 1003-1010, 1993.
18. Liu B, Maher RJ, Hannun YA, Porter AT and Honn KV, 12(S)-HETE enhancement of prostate tumor cell invasion: Selective role of PKCα. J Natl Cancer Inst 86: 1145-1151, 1994.
19. Honn KV, Timar J, Rozhin J, Bazaz R, Sameni M, Ziegler G and Sloane BF, A lipoxygenase metabolite, 12(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp Cell Res 214: 120-130, 1994.
20. Funk CD, Furci L and Fitzgerald GA, Molecular cloning, primary structure, and expression of the human platelet/ erythroleukemia cell 12-lipoxygenase. Proc Natl Acad Sci USA 87: 5638-5642, 1990.
21. Chen YQ, Duniec ZM, Liu B, Hagmann W, Gao X, Marnett LJ, Johnson CR and Honn KV, Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res 54: 1574-1579, 1994.
22. Buchdunger E, Trinks U, Mett H, Regenass U, Müller M, Meyer T, McGlynn E, Pinna LA, Traxler P and Lydon NB, 4,5-Dianilinophthalimide: A protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity. Proc Natl Acad Sci USA 91: 2334-2338, 1994.
23. Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW and Bridges AJ, A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265: 1093-1095, 1994.
24. Sambrook J, Fritsch EF and Maniatis T, Molecular Cloning. Cold Spring Harbor Laboratory Press, New York, 1989.
25. Jacobsson P-J, Steinhilber D, Odlander B, Rådmark O, Claesson H-E and Samuelsson B, On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc Natl Acad Sci USA 89: 3521-3525, 1992.
26. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye binding. Anal Biochem 72: 248-254, 1976.
27. Chen X-S, Brash AR and Funk CD, Purification and characterization of recombinant histidine-tagged human platelet 12-lipoxygenase expressed in a baculovirus/insect cell system. Eur J Biochem 214: 845-852, 1993.
28. Liu B, Timar J, Howlett J, Diglio CA and Honn KV, Lipoxygenase metabolites of arachidonic and linoleic acid modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C. Cell Regul 2: 1045-1055, 1991.
29. 2+-dependent translocation to membranes. Prostaglandins 46: 471-477, 1993.
30. 2+-dependent translocation from cytosol to membranes. Prostaglandins 49: 49-62, 1995.
31. Chang W-C, Kao H-C and Liu Y-W, Down-regulation of epidermal growth factor-induced 12-lipoxygenase expression by glucocorticoids in human epidermoid carcinoma A431 cells. Biochem Pharmacol 50: 947-952, 1995.
32. Izumi T, Hoshiko S, Rådmark O and Samuelsson B, Cloning of the cDNA for human 12-lipoxygenase. Proc Natl Acad Sci USA 87: 7477-7481, 1990.
33. Honn KV, Tang DG, Grossi IM, Renaud C, Duniec ZM, Johnson CR and Diglio CA, Enhanced endothelial cell retraction mediated by 12(S)-HETE: A proposed mechanism for the role of platelets in tumor cell metastasis. Exp Cell Res 210: 1-9, 1994.
34. Liu B, Marnett LJ, Chaudhary A, Ji C, Blair IA, Johnson CR, Diglio CA and Honn KV, Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential. Lab Invest 70: 314-323, 1994.
35. Arakawa T, Nakamura M, Yoshimoto T and Yamamoto S, The transcriptional regulation of human arachidonate 12-lipoxygenase gene by NFkB/Rel. FEBS Lett 363: 105-110, 1995.
36. Gullick WJ, Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47: 87-98, 1991.
37. Hynes NE, Amplification and overexpression of the erb-2 gene in human cancers: Its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Semin Cancer Biol 4: 19-26, 1993.